G-BA issues positive final medical benefit assessment for BRILIQUE in Germany
15 December 2011 | By AstraZeneca
AstraZeneca announced that the German assessment body, the Federal Joint Committee (G-BA), has issued its final decision regarding the medical benefit of BRILIQUE (ticagrelor)...